News Articles
Comprehensive vaccine design for commensal disease progression
Friday, October 20th, 2017
Abcombi Completes I-Corps at NIH Program for Influenza Indication
Tuesday, March 28th, 2017
Abcombi representatives completed the February-March
2017 I-Corps at NIH program in which we refined the
company’s strategy for our influenza therapeutic.
Abcombi takes home $50,000 in the Critical Path Accelerator Program
Thursday, January 12th, 2017
Abcombi took home $50,000 during at the conclusion
of the Critical Path Accelerator Program
Abcombi selected as a 43North 2016 Finalist
Monday, October 10th, 2016
Abcombi has been announced as a 2016 Finalist for
the 43North Business Plan Competition.
Abcombi Takes Home the Grand Prize at Bright Buffalo
Wednesday, June 15th, 2016
Abcombi Biosciences pitched at the Bright Buffalo
Niagara Entrepreneur Expo and took home the
grand prize of $20,000.